HURA

TuHURA BiosciencesA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

25%

Probability

Target price

$2.87

+31.7% vs current

Most likely

Base case

55%

Probability

Target price

$2.26

+3.7% vs current

B-

Bear case

20%

Probability

Target price

$1.44

-33.9% vs current

AI sentiment snapshot

Latest data as of 2025-11-17

AI commentary

Market interest appears muted with thin liquidity and limited public coverage; the official recent close anchor underscores a low-volume microcap profile [#RA-2025-11-14]. Investor focus is likely binary (clinical/financing events), so sentiment swings quickly on news [#RA-2025-11-14]. Coverage and filings visibility remain limited, increasing volatility for any headline [#RA-2025-11-14].

RankAlpha Sentiment AI - 2025-11-17

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

-eventCash-runway / financing update (public disclosure)High impact

Any disclosure of cash runway or a financing plan (dilution vs runway clarity) typically moves small biotech names; market likely reacts within days of a release [#RA-2025-11-14].

-catalystDownside from equity financing / dilutionHigh impact

High probability of dilutive financing for microcap biotech with limited cash could cause sharp share-price declines if large issuance occurs [#RA-2025-11-14].

-catalystClinical-stage program progression / trial startHigh impact

Initiation or positive early results in a clinical program could re-rate the microcap; currently low visibility and limited coverage [#RA-2025-11-14].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2025-11-17 • Updated nightlySource: Internal modelMethodology